Paper notes

Multiantigen print immunoassay (MAPIA) for the diagnosis of neurocysticercosis: a single-center diagnostic optimization and accuracy study in Lima, Peru

Toribio L., Guzman C., Noazin S., A. Zimic-Sheen, et al.

Time to read 3 min read Publication date 2023 Status Published Notes written April 25, 2026

A diagnostic optimization study evaluating a multiantigen print immunoassay for neurocysticercosis in a Lima clinical setting.

Readable notes

Reading guide

Summary

This study evaluates a multiantigen print immunoassay for neurocysticercosis diagnosis using clinical samples from Lima, Peru. The analysis focuses on antigen selection, diagnostic performance, and interpretation of multiantigen signal patterns.

Key findings

  • A selected multiantigen MAPIA format showed strong diagnostic performance for neurocysticercosis.
  • Combining several antigen signals helped support interpretation across clinically relevant sample groups.
  • The assay format provides an alternative to diagnostic workflows that require more specialized materials or infrastructure.

Technical contribution

The work included analysis, software support, validation, visualization, and manuscript writing.

Study context

The study addresses diagnostic optimization for neurocysticercosis using samples from a clinical setting in Lima, with emphasis on assay accuracy and practical implementation.

More papers

Read another paper note